These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 29127147

  • 1. IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium.
    Zhang Y, Dominguez-Medina C, Cumley NJ, Heath JN, Essex SJ, Bobat S, Schager A, Goodall M, Kracker S, Buckley CD, May RC, Kingsley RA, MacLennan CA, López-Macías C, Cunningham AF, Toellner KM.
    J Immunol; 2017 Dec 15; 199(12):4103-4109. PubMed ID: 29127147
    [Abstract] [Full Text] [Related]

  • 2. [Purification of Salmonella Typhimurium OmpD porin induces long-term high levels of antibodies: implications on the development of vaccines against non-typhoid salmonella].
    Pérez-Toledo M, Martínez-Amador PA, Pastelin-Palacios R, Isibasi A, Cunningham AF, López-Macías C.
    Gac Med Mex; 2016 Oct 15; 152(Suppl 2):5-13. PubMed ID: 27792711
    [Abstract] [Full Text] [Related]

  • 3. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.
    Schager AE, Dominguez-Medina CC, Necchi F, Micoli F, Goh YS, Goodall M, Flores-Langarica A, Bobat S, Cook CNL, Arcuri M, Marini A, King LDW, Morris FC, Anderson G, Toellner KM, Henderson IR, López-Macías C, MacLennan CA, Cunningham AF.
    mBio; 2018 Mar 06; 9(2):. PubMed ID: 29511082
    [Abstract] [Full Text] [Related]

  • 4. Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface.
    Domínguez-Medina CC, Pérez-Toledo M, Schager AE, Marshall JL, Cook CN, Bobat S, Hwang H, Chun BJ, Logan E, Bryant JA, Channell WM, Morris FC, Jossi SE, Alshayea A, Rossiter AE, Barrow PA, Horsnell WG, MacLennan CA, Henderson IR, Lakey JH, Gumbart JC, López-Macías C, Bavro VN, Cunningham AF.
    Nat Commun; 2020 Feb 12; 11(1):851. PubMed ID: 32051408
    [Abstract] [Full Text] [Related]

  • 5. Natural and vaccine-mediated immunity to Salmonella Typhimurium is impaired by the helminth Nippostrongylus brasiliensis.
    Bobat S, Darby M, Mrdjen D, Cook C, Logan E, Auret J, Jones E, Schnoeller C, Flores-Langarica A, Ross EA, Vira A, López-Macías C, Henderson IR, Alexander J, Brombacher F, Horsnell WG, Cunningham AF.
    PLoS Negl Trop Dis; 2014 Dec 12; 8(12):e3341. PubMed ID: 25474738
    [Abstract] [Full Text] [Related]

  • 6. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.
    Goh YS, Clare S, Micoli F, Saul A, Mastroeni P, MacLennan CA.
    Infect Immun; 2015 Sep 12; 83(9):3722-31. PubMed ID: 26169269
    [Abstract] [Full Text] [Related]

  • 7. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
    Jazani NH, Parsania S, Sohrabpour M, Mazloomi E, Karimzad M, Shahabi S.
    Immunobiology; 2011 Jun 12; 216(6):744-51. PubMed ID: 21093956
    [Abstract] [Full Text] [Related]

  • 8. Immunoprotection by monoclonal antibodies to the porins and lipopolysaccharide of Salmonella typhimurium.
    Singh SP, Williams YU, Benjamin WH, Klebba PE, Boyd D.
    Microb Pathog; 1996 Oct 12; 21(4):249-63. PubMed ID: 8905614
    [Abstract] [Full Text] [Related]

  • 9. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
    Svenson SB, Nurminen M, Lindberg AA.
    Infect Immun; 1979 Sep 12; 25(3):863-72. PubMed ID: 387597
    [Abstract] [Full Text] [Related]

  • 10. Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response.
    Secundino I, López-Macías C, Cervantes-Barragán L, Gil-Cruz C, Ríos-Sarabia N, Pastelin-Palacios R, Villasis-Keever MA, Becker I, Puente JL, Calva E, Isibasi A.
    Immunology; 2006 Jan 12; 117(1):59-70. PubMed ID: 16423041
    [Abstract] [Full Text] [Related]

  • 11. Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.
    Galdiero M, De Martino L, Marcatili A, Nuzzo I, Vitiello M, Cipollaro de l'Ero G.
    Immunology; 1998 May 12; 94(1):5-13. PubMed ID: 9708180
    [Abstract] [Full Text] [Related]

  • 12. Structural relatedness of enteric bacterial porins assessed with monoclonal antibodies to Salmonella typhimurium OmpD and OmpC.
    Singh SP, Upshaw Y, Abdullah T, Singh SR, Klebba PE.
    J Bacteriol; 1992 Mar 12; 174(6):1965-73. PubMed ID: 1312535
    [Abstract] [Full Text] [Related]

  • 13. Influence of immunopotentiators on the antiporin immunoglobulin G subclass: distribution and protective immunity against murine salmonellosis.
    Nandakumar KS, Muthukkaruppan VR.
    Scand J Immunol; 1999 Aug 12; 50(2):188-94. PubMed ID: 10447924
    [Abstract] [Full Text] [Related]

  • 14. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
    McLay J, Leonard E, Petersen S, Shapiro D, Greenspan NS, Schreiber JR.
    J Immunol; 2002 Apr 01; 168(7):3437-43. PubMed ID: 11907102
    [Abstract] [Full Text] [Related]

  • 15. Specificity of protective immunity induced by porin from Salmonella typhimurium.
    Matsui K, Arai T.
    Microbiologica; 1991 Apr 01; 14(2):103-12. PubMed ID: 1649959
    [Abstract] [Full Text] [Related]

  • 16. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Jazani NH, Sohrabpour M, Mazloomi E, Shahabi S.
    FEMS Immunol Med Microbiol; 2011 Feb 01; 61(1):54-62. PubMed ID: 21054579
    [Abstract] [Full Text] [Related]

  • 17. Candidate live, attenuated Salmonella enterica serotype Typhimurium vaccines with reduced fecal shedding are immunogenic and effective oral vaccines.
    Abd El Ghany M, Jansen A, Clare S, Hall L, Pickard D, Kingsley RA, Dougan G.
    Infect Immun; 2007 Apr 01; 75(4):1835-42. PubMed ID: 17296764
    [Abstract] [Full Text] [Related]

  • 18. Protective immunity induced by porin against Salmonella infection in mice.
    Udhayakumar V, Muthukkaruppan V.
    Indian J Med Res; 1989 May 01; 89():121-7. PubMed ID: 2550363
    [Abstract] [Full Text] [Related]

  • 19. Cinobufagin enhances the protective efficacy of formalin-inactivated Salmonella typhimurium vaccine through Th1 immune response.
    Wu SC, Yi PF, Guo X, Zhang LY, Xu DX, Fu YX, Cui ZQ, Shen HQ, Wei XB, Fu BD.
    Microb Pathog; 2016 Oct 01; 99():264-270. PubMed ID: 27574776
    [Abstract] [Full Text] [Related]

  • 20. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
    Jackson RJ, Staats HF, Xu-Amano J, Takahashi I, Kiyono H, Hudson ME, Gilley RM, Chatfield SN, McGhee JR.
    Ann N Y Acad Sci; 1994 Aug 15; 730():217-34. PubMed ID: 8080173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.